194 related articles for article (PubMed ID: 1378314)
1. Inhibition of angiogenesis.
Folkman J; Ingber D
Semin Cancer Biol; 1992 Apr; 3(2):89-96. PubMed ID: 1378314
[TBL] [Abstract][Full Text] [Related]
2. Advances in understanding angiogenesis through molecular studies.
Kwon M; Libutti SK
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):26-32. PubMed ID: 16377412
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of tumor angiogenesis as a cancer treatment].
Verheul HM; Bom JB; Hoekman K; Pinedo HM
Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1549-55. PubMed ID: 10443279
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis research: guidelines for translation to clinical application.
Folkman J; Browder T; Palmblad J
Thromb Haemost; 2001 Jul; 86(1):23-33. PubMed ID: 11487011
[TBL] [Abstract][Full Text] [Related]
5. [Angiogenesis and antiangiogenic cancer therapy].
Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
[TBL] [Abstract][Full Text] [Related]
6. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
Plavetić ND; Letilović T; Vrbanec D
Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis--a new target for future therapy.
Pandya NM; Dhalla NS; Santani DD
Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
[TBL] [Abstract][Full Text] [Related]
8. Tumor angiogenesis--a potential target in cancer chemoprevention.
Bhat TA; Singh RP
Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
[TBL] [Abstract][Full Text] [Related]
9. Vascular targeting and the inhibition of angiogenesis.
Bicknell R
Ann Oncol; 1994; 5 Suppl 4():45-50. PubMed ID: 7520262
[TBL] [Abstract][Full Text] [Related]
10. Tumor angiogenesis: biology and therapeutic prospects.
Harris SR; Thorgeirsson UP
In Vivo; 1998; 12(6):563-70. PubMed ID: 9891218
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic cancer therapy.
Cao Y
Semin Cancer Biol; 2004 Apr; 14(2):139-45. PubMed ID: 15018898
[TBL] [Abstract][Full Text] [Related]
12. [The clinical perspective of angiogenesis inhibitors].
Radema SA; Witteveen PO; Gebbink MB; Voest EE
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic strategies for cancer therapy (Review).
Benouchan M; Colombo BM
Int J Oncol; 2005 Aug; 27(2):563-71. PubMed ID: 16010440
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma.
Lingen MW; Polverini PJ; Bouck NP
Cancer Res; 1998 Dec; 58(23):5551-8. PubMed ID: 9850093
[TBL] [Abstract][Full Text] [Related]
16. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
17. Current strategies and future directions of antiangiogenic tumor therapy.
Zhang ZL; Wang JH; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):873-80. PubMed ID: 14515202
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
Cao Y
Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
[TBL] [Abstract][Full Text] [Related]
19. Endogenous angiogenesis inhibitors.
Folkman J
APMIS; 2004; 112(7-8):496-507. PubMed ID: 15563312
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
Folkman J
Exp Cell Res; 2006 Mar; 312(5):594-607. PubMed ID: 16376330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]